Table of Contents
Table of Contents
Preface
Chapter 1 – Regulation of GABA Synthesis and Transport (pp. 1-12)
Jigar Pravinchandra Modi, Howard Prentice and Jang-Yen Wu (College of Medicine, Florida Atlantic University, FL, US and others)
Chapter 2 – GABA Metabolism in Saccharomyces cerevisiae (pp. 13-28)
Susana Correa-García and Mariana Bermúdez-Moretti (Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires – IQUIBICEN, CONICET, Argentina)
Chapter 3 – The Effects of Persistent Activation of GABAA Receptors by Neurotransmitter GABA (pp. 29-48)
Josipa Vlainić, Dubravka Švob Štrac and Maja Jazvinšćak Jembrek (Rudjer Boskovic Institute, Department of Molecular Medicine, Laboratory of Molecular Neuropharmacology, Zagreb, Croatia)
Chapter 4 – The Role of GABA in Development and Behaviour: Emphasis on the Effects of GABA Receptor Agonists and Antagonists (pp. 49-70)
Maja Jazvinšćak Jembrek, Josipa Vlainić and Vedrana Radovanović (Laboratory for Molecular Neuropharmacology, Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia)
Chapter 5 – The Effects of GABA and GABAergic Drugs on the HPA Axis Activity (pp. 71-92)
Dubravka Svob Strac, Dorotea Muck-Seler and Nela Pivac (Rudjer Boskovic Institute, Division of Molecular Medicine, Zagreb, Croatia)
Chapter 6 – GABAergic Drugs in the Treatment of Cerebellar Ataxia and Other Motor Disorders of the Central Nervous System (pp. 93-108)
José Gazulla, Carlota Ruiz-Gazulla and María Tintoré (Department of Neurology, Hospital Universitario Miguel Servet. Zaragoza; Faculty of Science, University of Zaragoza, and Nucleic Acid Chemistry, Institute for Advanced Chemistry of Catalonia, Barcelona CSIC, Spain)
Chapter 7 – GABA-Mediated over-Inhibition in Down Syndrome: Implications for Cognitive and Neuromorphological Phenotypes (pp. 109-132)
Paula Martínez and Carmen Martínez-Cué (Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander, Spain)
Chapter 8 – Behavioral and Psychological Symptoms of Dementia and GABAergic System: Implications for Treatment (pp. 133-158)
Maite Solas and Maria J. Ramirez (Department of Pharmacology and Toxicology, University of Navarra, Pamplona, Spain)
Chapter 9 – GABAergic System and Alzheimer’s Disease (pp. 159-180)
Claudio De Piazza (Neurology Unit, Valduce Hospital, Como, Italy)
Chapter 10 – GABA Pharmacology in Veterinary Medicine: From Anesthesia to Phobias Treatment (pp. 181-196)
Jelena Šuran and Josipa Vlainić (Department of Pharmacology and Toxicology, Faculty of Veterinary medicine, University of Zagreb, Croatia)
Index